Celera Genomics Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 490

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 6

Celera Genomics General Information

Description

Provider of medical diagnostic services. The company caters to the healthcare industry and offers diagnostic testing and information services.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1401 Harbor Bay Parkway
  • Alameda, CA 94502
  • United States
+1 (510)
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 1401 Harbor Bay Parkway
  • Alameda, CA 94502
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celera Genomics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Celera Genomics‘s full profile, request access.

Request a free trial

Celera Genomics Patents

Celera Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140315844-A1 Multi-gene signatures for predicting response to chemotherapy or risk of metastasis for breast cancer Inactive 30-Nov-2012
WO-2014085653-A1 Multi-gene signatures for predicting response to chemotherapy or risk of metastasis for breast cancer Inactive 30-Nov-2012
WO-2012151305-A2 Genetic polymorphisms associated with short stature, methods of detection and uses thereof Inactive 03-May-2011
WO-2012151305-A3 Genetic polymorphisms associated with short stature, methods of detection and uses thereof Inactive 03-May-2011
US-8557525-B1 Composite metastasis score with weighted coefficients for predicting breast cancer metastasis, and uses thereof Active 25-Feb-2011 C12Q1/6886
To view Celera Genomics’s complete patent history, request access »

Celera Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celera Genomics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Celera Genomics‘s full profile, request access.

Request a free trial

Celera Genomics Investments & Acquisitions (6)

Celera Genomics’s most recent deal was a Merger/Acquisition with Forensic Analytical/Molecular Genetics for . The deal was made on 20-Oct-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Forensic Analytical/Molecular Genetics 20-Oct-2007 Merger/Acquisition Biotechnology
Berkeley HeartLab 15-Oct-2007 Merger/Acquisition Biotechnology
AXYS Pharmaceuticals 16-Nov-2001 Merger/Acquisition Biotechnology
HuBit genomix 23-Mar-2001 Corporate Drug Discovery
Sequana 01-Jan-2001 Merger/Acquisition Paper Containers and Packaging
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Celera Genomics Exits (1)

Celera Genomics’s most recent exit was on 01-Jan-2001 from Sequana. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Sequana 01-Jan-2001 Completed
To view Celera Genomics’s complete exits history, request access »

Celera Genomics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Sequana Boulogne-Billancourt, France 1847

Celera Genomics FAQs

  • When was Celera Genomics founded?

    Celera Genomics was founded in 1998.

  • Where is Celera Genomics headquartered?

    Celera Genomics is headquartered in Alameda, CA.

  • What is the size of Celera Genomics?

    Celera Genomics has 490 total employees.

  • What industry is Celera Genomics in?

    Celera Genomics’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Celera Genomics a private or public company?

    Celera Genomics is a Private company.

  • What is the current valuation of Celera Genomics?

    The current valuation of Celera Genomics is .

  • What is Celera Genomics’s current revenue?

    The current revenue for Celera Genomics is .

  • Who are Celera Genomics’s investors?

    AXA France Assurance, Applera, Asset Management Ventures, Fidelity Management & Research Company, and Flagship Pioneering are 5 of 7 investors who have invested in Celera Genomics.

  • When was Celera Genomics acquired?

    Celera Genomics was acquired on 17-May-2011.

  • Who acquired Celera Genomics?

    Celera Genomics was acquired by Quest Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process